BioSpace News Archive

Policy

Tainted Blood Pressure Drugs Causes FDA to Issue Recall Alert

The U.S. Food and Drug Administration issued a voluntary recall of a medication to treat high blood pressure due to trace amounts of a carcinogen being found within some lots of the drug.

November 1, 2018
·
2 min read
·
Alex Keown
Business

Early November Brings More Quarterly Reports

Biopharma companies set to release financial reports next week have reported positive news in recent months.

November 1, 2018
·
3 min read
·
Alex Keown
Business

CuraSen Therapeutics Expands Management Team; Industry Veteran and Neuroscience Expert Gabriel Vargas, MD, PhD, Appointed to Chief Medical Officer

CuraSen Therapeutics, Inc. today announced that it has appointed Gabriel Vargas, MD, PhD, as chief medical officer. Dr. Vargas brings to CuraSen more than 12 years of experience in early drug development and neuroscience expertise.

November 1, 2018
·
2 min read
Teva Reports Third Quarter 2018 Financial Results

Revenues of $4.5 billion

November 1, 2018
·
39 min read
Job Trends

Combined therapy including pelvic lymph node radiation provides significant benefit for prostate cancer patients

Trial shows that addition of pelvic lymph node treatment and short-term hormone therapy effective at controlling prostate cancer that recurs after prostatectomy

November 1, 2018
·
7 min read
Spectrum Cannabis welcomes JWC dried cannabis products to its online platform

Diversified offering reinforces commitment to medical customers

November 1, 2018
·
6 min read
Business

Intrexon to Announce Third Quarter 2018 Financial Results on November 8th

Intrexon Corporation today announced it will release third quarter 2018 financial results after the market closes on Thursday, November 8th, 2018. The Company will host a conference call that day at 5:30 PM ET to discuss the results and provide a general business update.

November 1, 2018
·
2 min read
Business

Provention Bio to Report Third Quarter 2018 Financial Results and Host Conference Call on Thursday, November 8, 2018

Provention Bio, Inc. announced today it will host a conference call and live audio webcast on Thursday, November 8, 2018, at 8:30 a.m. ET.

November 1, 2018
·
2 min read
Business

Aevi Genomic Medicine Reports Third Quarter 2018 Financial Results and Provides Business Update

Announced today financial and operational results for the three months ended September 30, 2018 and provided an overview of the Company’s recent corporate progress.

November 1, 2018
·
9 min read
FDA

FDA Clears VITROS® XT 7600 Integrated System from Ortho Clinical Diagnostics, Bringing Innovative New Approach to Clinical Lab Management

DIGITAL CHEMISTRY™ Technology Enables Powerful Data Intelligence, Operational Improvements and Other Enhancements in the Lab

November 1, 2018
·
3 min read